Le Lézard
Classified in: Health, Science and technology
Subject: Conference

An Essential Overview of the Pharmaceutical & Biotech Industries - 1-Day Programme (London, United Kingdom - May 4, 2020) - ResearchAndMarkets.com


The "An Essential Overview of the Pharmaceutical and Biotech Industries" conference has been added to ResearchAndMarkets.com's offering.

This programme will give you an invaluable overview, refresher and update on the pharmaceutical and biotechnology industries, from discovery of the molecule through development to marketing.

It will provide a step-by-step understanding of the main areas of drug development and will discuss the roles and responsibilities of key staff involved.

You will be given a comprehensive glossary of the most commonly used industry terms, which will be an invaluable reference to help you get to grips with the technical terminology and jargon.

Why You Should Attend

Who Should Attend?

All those wanting to achieve a better understanding of how the pharma/biotech industries work. The course will be particularly helpful for those wanting to understand what other departments do, for new staff working in the industry and for non-scientific and administrative personnel.

Agenda

How the pharma/biotech industries develop medicines

Demystifying the jargon and terminology

Roles and responsibilities of the people in the pharma/biotech industries

Clinical trials

Pharmacovigilance

Regulatory processes

Commercial considerations for how medicines are marketed and sold

Speaker

Laura Brown

Pharmaceutical QA & Training Consultant,

University of Cardiff

Dr Laura Brown MBA, BSc, PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.

She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including The Planning of International Drug Development, in the Clinical Research Manual, Euromed and the Impact of Brexit, RQA Journal 2017.

For more information about this conference visit https://www.researchandmarkets.com/r/tie28s


These press releases may also interest you

at 02:05
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the appointment of Dr. Gerard Short, MBBS, as Chief Medical Officer (CMO). As CMO, Dr. Short will be responsible for...

at 01:21
JANUARY 1 - DECEMBER 31, 2020 (compared with the corresponding period a year ago) Highest adjusted EBITA and highest adjusted EBITA margin everTarget raised for adjusted return on capital employed to above 17% by 2025Net sales declined 5.6% to SEK...

at 01:00
Sartorius Stedim Biotech, a leading partner of the biopharma industry, recorded exceptionally strong growth in 2020 that was driven by strong organic development, several acquisitions and additional momentum from business related to the coronavirus...

at 01:00
The life science group Sartorius recorded high growth according to preliminary figures in 2020 due to strong organic development, several acquisitions and the additional momentum from business related to the coronavirus pandemic. The Group closed the...

at 00:55
January 2021, Thousand Oaks Biopharmaceuticals Group ("Thousand Oaks") announced that it had signed a Joint Venture agreement with WSG Group in Busan, Korea, to establish a bioprocess solution joint venture (including cell culture media, single-use...

at 00:00
FDA Under the Biden Administration: What's to Come and What It Will Mean An FDAnews Webinar Wednesday, Feb.10, 2021, 1:30 p.m. ? 3:30 p.m. EST https://www.fdanews.com/fdaunderbiden Changes are coming to the FDA. With the Biden administration, there...



News published on 19 september 2019 at 14:35 and distributed by: